論文・総説 - 田中 一
-
Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;
-
Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;
-
Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;
-
Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;
-
Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;
-
ToshikiKijimaHajimeTanakaShoUeharaSoichiroYoshidaMinatoYokoyamaJunichiroIshiokaYohMatsuokaKazutakaSaitoKazunoriKiharaYasuhisaFujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;
-
Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )
-
Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed, DOI )
-
Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell. Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed, DOI )
-
Toshiki Kijima, Hajime Tanaka, Fumitaka Koga, Hitoshi Masuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int.. 2019.08; 124 (2): 242-250. ( PubMed, DOI )
-
Masaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, Noboru Numao, Junji Yonese, Masaya Ito, Fumitaka Koga, Hiroshi Fukushima, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int. J. Urol.. 2019.08; 26 (8): 820-826. ( PubMed, DOI )
-
Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell. The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed, DOI )
-
Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed, DOI )
-
Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 転移性尿路上皮癌患者の化学療法感受性と生存率にPET/CTでのフルオロデオキシグルコース取り込みが及ぼす影響(Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma) International Journal of Urology. 2019.08; 26 (8): 820-826. ( 医中誌 )
-
Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell. Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed, DOI )
-
Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.04; 44 (4): 1230-1236. ( PubMed, DOI )
-
Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell. Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed, DOI )
-
Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell. Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed, DOI )
-
Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell. Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed, DOI )
-
Naoko Kawamura, Minato Yokoyama, Hajime Tanaka, Takayuki Nakayama, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. Int. J. Urol.. 2019.01; 26 (1): 113-118. ( PubMed, DOI )